• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医疗器械开发的责任与后果。

The liabilities and consequences of medical device development.

作者信息

Price J M

出版信息

J Biomed Mater Res. 1987 Apr;21(A1 Suppl):35-58.

PMID:3571302
Abstract

A large increase in medical products liability litigation during the past 40 years has resulted in a flood of litigation against drug and device manufacturers. The medical technology and chemical industries are prime targets for products liability litigation. Physicians and other health care providers are willing to accept a reasonable degree of risk associated with the use of a medical product when compared to the benefit to be achieved by that product but lay juries are less likely to tolerate the concept of an acceptable failure rate. Plaintiffs' lawyers believe that the medical products industry should be held to a standard of absolute liability and that anyone injured by a medical product is entitled to recover without regard for the circumstances. Large compensatory and punitive damage awards, the high cost of insurance, large defense costs, and low profit margins have forced some companies to remove their products from the market. The medical or biomaterials manufacturer can significantly reduce its exposure for products liability by adopting a successful product safety program. Manufacturers have significant control over the quality, safety, and reliability of their products through appropriate design, testing, manufacture, labeling, and sale of quality products.

摘要

在过去40年里,医疗产品责任诉讼大幅增加,导致针对药品和器械制造商的诉讼泛滥成灾。医疗技术和化工行业是产品责任诉讼的主要目标。与使用医疗产品所带来的益处相比,医生和其他医疗保健提供者愿意接受与使用该产品相关的合理程度的风险,但普通陪审团不太可能容忍可接受故障率的概念。原告律师认为,医疗产品行业应遵循绝对责任标准,任何因医疗产品而受伤的人都有权获得赔偿,而无需考虑具体情况。巨额的补偿性和惩罚性损害赔偿裁决、高昂的保险成本、庞大的辩护费用以及微薄的利润率,迫使一些公司将其产品撤出市场。医疗或生物材料制造商可以通过实施成功的产品安全计划,显著降低其面临的产品责任风险。制造商通过对产品进行适当的设计、测试、制造、标签标注以及销售优质产品,对其产品的质量、安全性和可靠性拥有重大控制权。

相似文献

1
The liabilities and consequences of medical device development.医疗器械开发的责任与后果。
J Biomed Mater Res. 1987 Apr;21(A1 Suppl):35-58.
2
[Suspension of IUD sales in the United States: what are the international implications?].[美国宫内节育器销售暂停:有哪些国际影响?]
Perspect Int Planif Fam. 1987(Spec No):28-34.
3
Introducing new contraceptives.推出新型避孕药具。
Draper Fund Rep. 1986 Dec(15):27-32.
4
Statutory caps: an involuntary contribution to the medical malpractice insurance crisis or a reasonable mechanism for obtaining affordable health care?法定上限:是对医疗事故保险危机的非自愿贡献,还是获得可负担医疗保健的合理机制?
J Contemp Health Law Policy. 1993 Spring;9:337-75.
5
The changing environment for technological innovation in health care.医疗保健领域技术创新环境的变化
Baxter Health Policy Rev. 1996;2:267-315.
6
Design and implementation of a portal for the medical equipment market: MEDICOM.医疗设备市场门户MEDICOM的设计与实现
J Med Internet Res. 2001 Oct-Dec;3(4):E32. doi: 10.2196/jmir.3.4.e32.
7
Comment: litigation involving manufacturers' liability for defective medical products: judicial perspectives.
Am J Law Med. 1976;2(2):245-55.
8
The use and abuse of warnings in products liability--design defect litigation comes of age.
Cornell Law Rev. 1976 Apr;61(4):495-540.
9
Safe Medical Devices Act: management guidance for hospital compliance with the new FDA requirements.《安全医疗器械法案》:医院遵守美国食品药品监督管理局新要求的管理指南
Hosp Technol Ser. 1993 Oct;12(11):1-27.
10
Liability of manufacturers and providers of health related goods and services: confronting the dilemma.
Am J Law Med. 1976;2(2):257-62.